Lv3
286 积分 2022-10-31 加入
Clinical implications of residual normal plasma cells within bone marrow across various disease stages in multiple myeloma
1天前
待确认
Primary central nervous system marginal zone lymphoma
1个月前
已完结
Emerging biomarkers for CD3×CD20 bispecific antibodies in lymphoma
1个月前
已完结
CD20 xCD3 bispecific antibodies for large B cell lymphoma: latest updates from 2024 ASH annual meeting
1个月前
已关闭
Epcoritamab monotherapy in patients with relapsed or refractory follicular lymphoma (EPCORE NHL-1): a phase 2 cohort of a single-arm, multicentre study
1个月前
已完结
Belantamab mafodotin plus bortezomib and dexamethasone in patients with relapsed or refractory multiple myeloma (DREAMM-7): updated overall survival analysis from a global, randomised, open-label, phase 3 trial
1个月前
已完结
Slit-Lamp Biomicroscope
1个月前
已关闭
Belantamab mafodotin plus bortezomib and dexamethasone in patients with relapsed or refractory multiple myeloma (DREAMM-7): updated overall survival analysis from a global, randomised, open-label, phase 3 trial
1个月前
已完结
Ocular surface toxicities associated with modern anticancer therapies
1个月前
已完结
Hitting the Therapeutic Bullseye with Targeted Therapy for Patients with Chronic Lymphocytic Leukemia
1个月前
已完结
皖公网安备34019202002308
